TY  - CONF

T1  - SCHIZOPHRENIA TREATMENT WITH SECOND-GENERATION ANTIPSYCHOTICS: A MULTI-COUNTRY EVALUATION OF THE COSTS OF CARDIOVASCULAR AND METABOLIC ADVERSE EVENTS AND WEIGHT GAIN

JO  - VALUE IN HEALTH

PY  - 2020/01/01

AU  - Kearns B

AU  - Cooper K

AU  - Cantrell A

ED  - 

VL  - 23

SP  - S605

EP  - S605

Y2  - 2024/12/21

ER  -